31.40
+0.80
+(2.61%)
At close: January 31 at 5:26:51 PM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 6YG.MU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Reiterates | Needham: Buy to Buy | 1/10/2025 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 12/13/2024 |
| Downgrade | Mizuho: Outperform to Neutral | 11/11/2024 |
| Maintains | Needham: Buy to Buy | 11/7/2024 |
| Initiated | UBS: Sell | 10/24/2024 |
Related Tickers
1JK.F Apellis Pharmaceuticals, Inc.
28.59
+3.40%
2L9.SG Blueprint Medicines Corp
107.90
-0.55%
LT4.F Liquidia Corporation
13.76
+1.33%
63E.MU Onward Medical NV
6.34
-6.49%
63E.F Onward Medical N.V.
6.50
-2.11%
ASEP.CN ASEP Medical Holdings Inc.
0.0650
-13.33%
5CV.F CureVac N.V.
3.6520
-1.78%
ONWD.BR Onward Medical N.V.
6.36
+0.95%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
CAMP CAMP4 THERAPEUTICS CORPORATION
4.8100
-18.47%